September 14, 2021
RFA-CA-21-057 - A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed)
RFA-CA-21-058 - Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The National Cancer Institute (NCI) will hold one joint technical assistance webinar on Friday, October 1st, 2021 from 1:00 PM to 3:00 PM, for institutions planning to submit applications in response to the funding opportunity announcements (FOAs) RFA-CA-21-057 - A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed) and RFA-CA-21-058 - Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed).
The purpose of this webinar is to provide potential applicants with pertinent information related to both FOAs and answer any questions that they may have about the intent and requirements concerning each. Representatives from NCI program staff will be available to respond to any questions related to the proposed new program, including the cooperative agreement mechanism, the roles of the Steering Committee, development of the application, the review process, grants management, among others.
Webinar Information
To join the Webinar, pre-registration is required through WebEx
or use the link: https://cbiit.webex.com/cbiit/j.php?MTID=m6fc27b63e3029fa52d06e8ded088864a
Specific Webinar information including the webinar link will be provided upon registration.
Attendance at this webinar is optional and not required for application submission. The webinar will be recorded for those who cannot attend the live event. To request a copy of the webinar or submit additional questions, please contact NCI Program Support Staff at [email protected].
Sandra San Miguel, M.S.
Program Director
National Cancer Institute (NCI)
Telephone: 240-276-5977
Email: [email protected]